Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κB

Raman P. Nagarajan, Feifei Chen, Wei Li, Eva Vig, Maureen Harrington, Harikrishna Nakshatri, Yan Chen

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Activation of transforming growth factor-β (TGF-β) and activin receptors leads to phosphorylation of Sma- and Mad-related protein 2 (Smad2) and Smad3, which function as transcription factors to regulate gene expression. Smad7 is a regulatory protein which is able to inhibit TGF-β and activin signalling in a negative-feedback loop, mediated by a direct regulation by Smad3 and Smad4 via a Smad-binding element (SBE) in the Smad7 promoter. Interestingly, we found that the Smad7 promoter was also regulated by nuclear factor κB (NF-κB), a transcription factor which plays an important role in inflammation and the immune response. Expression of NF-κB p65 subunit was able to inhibit the Smad7 promoter activity, and this inhibition could be reversed by co-expression of IκB, an inhibitor of NF-κB. In addition, the inhibitory activity of p65 was observed in a minimal promoter that contained only the Smad7 SBE and a TATA box, without any consensus NF-κB binding site. This inhibitory effect appeared to be common to other TGF-β- and activin-responsive promoters, since p65 also inhibited the forkhead-activin-signal-transducer-2-mediated activation of a Xenopus Mix.2 promoter, as well as the Smad3-mediated activation of 3TP-lux which contains PMA-responsive elements and a plasminogen-activator-inhibitor-1 promoter. Activation of endogenous NF-κB by tumour necrosis factor-α (TNF-α) was also able to inhibit the Smad7 promoter in human embryonic kidney 293 cells. In human hepatoma HepG2 cells, TNF-α was able to inhibit TGF-β- and activin-mediated transcriptional activation. Furthermore, overexpression of the transcription coactivator p300 could abrogate the inhibitory effect of NF-κB on the Smad7 promoter. Taken together, these data have indicated a novel mode of crosstalk between the Smad and the NF-κB signalling cascades at the transcriptional level by competing for a limiting pool of transcription co-activators.

Original languageEnglish
Pages (from-to)591-596
Number of pages6
JournalBiochemical Journal
Volume348
Issue number3
DOIs
StatePublished - Jun 15 2000

Fingerprint

Activins
Transforming Growth Factors
Transcription
Transcription Factors
Chemical activation
Tumor Necrosis Factor-alpha
Activin Receptors
Smad Proteins
TATA Box
Growth Factor Receptors
Plasminogen Activator Inhibitor 1
Hep G2 Cells
Xenopus
Transducers
Phosphorylation
Transcriptional Activation
Hepatocellular Carcinoma
Crosstalk
Gene expression
Binding Sites

Keywords

  • Activin
  • p300
  • Signal transduction
  • Smad7
  • Transcription factor

ASJC Scopus subject areas

  • Biochemistry

Cite this

Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κB. / Nagarajan, Raman P.; Chen, Feifei; Li, Wei; Vig, Eva; Harrington, Maureen; Nakshatri, Harikrishna; Chen, Yan.

In: Biochemical Journal, Vol. 348, No. 3, 15.06.2000, p. 591-596.

Research output: Contribution to journalArticle

Nagarajan, Raman P. ; Chen, Feifei ; Li, Wei ; Vig, Eva ; Harrington, Maureen ; Nakshatri, Harikrishna ; Chen, Yan. / Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κB. In: Biochemical Journal. 2000 ; Vol. 348, No. 3. pp. 591-596.
@article{5c82fbe1e4734218b93bc0f422400cb4,
title = "Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κB",
abstract = "Activation of transforming growth factor-β (TGF-β) and activin receptors leads to phosphorylation of Sma- and Mad-related protein 2 (Smad2) and Smad3, which function as transcription factors to regulate gene expression. Smad7 is a regulatory protein which is able to inhibit TGF-β and activin signalling in a negative-feedback loop, mediated by a direct regulation by Smad3 and Smad4 via a Smad-binding element (SBE) in the Smad7 promoter. Interestingly, we found that the Smad7 promoter was also regulated by nuclear factor κB (NF-κB), a transcription factor which plays an important role in inflammation and the immune response. Expression of NF-κB p65 subunit was able to inhibit the Smad7 promoter activity, and this inhibition could be reversed by co-expression of IκB, an inhibitor of NF-κB. In addition, the inhibitory activity of p65 was observed in a minimal promoter that contained only the Smad7 SBE and a TATA box, without any consensus NF-κB binding site. This inhibitory effect appeared to be common to other TGF-β- and activin-responsive promoters, since p65 also inhibited the forkhead-activin-signal-transducer-2-mediated activation of a Xenopus Mix.2 promoter, as well as the Smad3-mediated activation of 3TP-lux which contains PMA-responsive elements and a plasminogen-activator-inhibitor-1 promoter. Activation of endogenous NF-κB by tumour necrosis factor-α (TNF-α) was also able to inhibit the Smad7 promoter in human embryonic kidney 293 cells. In human hepatoma HepG2 cells, TNF-α was able to inhibit TGF-β- and activin-mediated transcriptional activation. Furthermore, overexpression of the transcription coactivator p300 could abrogate the inhibitory effect of NF-κB on the Smad7 promoter. Taken together, these data have indicated a novel mode of crosstalk between the Smad and the NF-κB signalling cascades at the transcriptional level by competing for a limiting pool of transcription co-activators.",
keywords = "Activin, p300, Signal transduction, Smad7, Transcription factor",
author = "Nagarajan, {Raman P.} and Feifei Chen and Wei Li and Eva Vig and Maureen Harrington and Harikrishna Nakshatri and Yan Chen",
year = "2000",
month = "6",
day = "15",
doi = "10.1042/0264-6021:3480591",
language = "English",
volume = "348",
pages = "591--596",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κB

AU - Nagarajan, Raman P.

AU - Chen, Feifei

AU - Li, Wei

AU - Vig, Eva

AU - Harrington, Maureen

AU - Nakshatri, Harikrishna

AU - Chen, Yan

PY - 2000/6/15

Y1 - 2000/6/15

N2 - Activation of transforming growth factor-β (TGF-β) and activin receptors leads to phosphorylation of Sma- and Mad-related protein 2 (Smad2) and Smad3, which function as transcription factors to regulate gene expression. Smad7 is a regulatory protein which is able to inhibit TGF-β and activin signalling in a negative-feedback loop, mediated by a direct regulation by Smad3 and Smad4 via a Smad-binding element (SBE) in the Smad7 promoter. Interestingly, we found that the Smad7 promoter was also regulated by nuclear factor κB (NF-κB), a transcription factor which plays an important role in inflammation and the immune response. Expression of NF-κB p65 subunit was able to inhibit the Smad7 promoter activity, and this inhibition could be reversed by co-expression of IκB, an inhibitor of NF-κB. In addition, the inhibitory activity of p65 was observed in a minimal promoter that contained only the Smad7 SBE and a TATA box, without any consensus NF-κB binding site. This inhibitory effect appeared to be common to other TGF-β- and activin-responsive promoters, since p65 also inhibited the forkhead-activin-signal-transducer-2-mediated activation of a Xenopus Mix.2 promoter, as well as the Smad3-mediated activation of 3TP-lux which contains PMA-responsive elements and a plasminogen-activator-inhibitor-1 promoter. Activation of endogenous NF-κB by tumour necrosis factor-α (TNF-α) was also able to inhibit the Smad7 promoter in human embryonic kidney 293 cells. In human hepatoma HepG2 cells, TNF-α was able to inhibit TGF-β- and activin-mediated transcriptional activation. Furthermore, overexpression of the transcription coactivator p300 could abrogate the inhibitory effect of NF-κB on the Smad7 promoter. Taken together, these data have indicated a novel mode of crosstalk between the Smad and the NF-κB signalling cascades at the transcriptional level by competing for a limiting pool of transcription co-activators.

AB - Activation of transforming growth factor-β (TGF-β) and activin receptors leads to phosphorylation of Sma- and Mad-related protein 2 (Smad2) and Smad3, which function as transcription factors to regulate gene expression. Smad7 is a regulatory protein which is able to inhibit TGF-β and activin signalling in a negative-feedback loop, mediated by a direct regulation by Smad3 and Smad4 via a Smad-binding element (SBE) in the Smad7 promoter. Interestingly, we found that the Smad7 promoter was also regulated by nuclear factor κB (NF-κB), a transcription factor which plays an important role in inflammation and the immune response. Expression of NF-κB p65 subunit was able to inhibit the Smad7 promoter activity, and this inhibition could be reversed by co-expression of IκB, an inhibitor of NF-κB. In addition, the inhibitory activity of p65 was observed in a minimal promoter that contained only the Smad7 SBE and a TATA box, without any consensus NF-κB binding site. This inhibitory effect appeared to be common to other TGF-β- and activin-responsive promoters, since p65 also inhibited the forkhead-activin-signal-transducer-2-mediated activation of a Xenopus Mix.2 promoter, as well as the Smad3-mediated activation of 3TP-lux which contains PMA-responsive elements and a plasminogen-activator-inhibitor-1 promoter. Activation of endogenous NF-κB by tumour necrosis factor-α (TNF-α) was also able to inhibit the Smad7 promoter in human embryonic kidney 293 cells. In human hepatoma HepG2 cells, TNF-α was able to inhibit TGF-β- and activin-mediated transcriptional activation. Furthermore, overexpression of the transcription coactivator p300 could abrogate the inhibitory effect of NF-κB on the Smad7 promoter. Taken together, these data have indicated a novel mode of crosstalk between the Smad and the NF-κB signalling cascades at the transcriptional level by competing for a limiting pool of transcription co-activators.

KW - Activin

KW - p300

KW - Signal transduction

KW - Smad7

KW - Transcription factor

UR - http://www.scopus.com/inward/record.url?scp=0034659813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034659813&partnerID=8YFLogxK

U2 - 10.1042/0264-6021:3480591

DO - 10.1042/0264-6021:3480591

M3 - Article

C2 - 10839991

AN - SCOPUS:0034659813

VL - 348

SP - 591

EP - 596

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 3

ER -